Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Can molecular markers predict local, regional and distant metastasis in head and neck cancer?

Nature Clinical Practice Oncology volume 2, pages 132–133 (2005)Cite this article

boxed-textAtaman OU et al. (2004) Molecular biomarkers and site of first recurrence after radiotherapy for head and neck cancer. Eur J Cancer 40: 2734–2741

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Smith B and Haffty BG (2002) Prognostic factors in head and neck cancer. In Head and Neck Cancer: A Multidisciplinary Approach, 2nd ed (Eds Harrison L et al.) Philadelphia: Lippincott-Raven Publishers

    Google Scholar 

  2. Cho EI et al. (2004) Tissue microarray analysis reveals prognostic significance of COX-2 expression for local relapse in T1-2N0 larynx cancer treated with primary radiation therapy. Laryngoscope 114: 2001–2008

    Article  CAS  Google Scholar 

  3. Harari PM et al. (2001) Head and neck cancer as a clinical model for molecular targeting of therapy: combining EGFR blockade with radiation. Int J Radiat Oncol Biol Phys 49: 427–433

    Article  CAS  Google Scholar 

  4. Smith BD et al. (2000) Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma. J Clin Oncol 18: 2046–2052

    Article  CAS  Google Scholar 

  5. Eriksen JG et al. (2004) Molecular profiles as predictive marker for the effect of overall treatment time of radiotherapy in supraglottic larynx squamous cell carcinomas. Radiother Oncol 72: 275–282

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Professor and Vice-Chairman at the Department of Therapeutic Radiology, Yale School of Medicine and Yale-New Haven Hospital, New Haven, CT, USA

    Bruce G Haffty

Authors
  1. Bruce G Haffty
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Glossary

COMPETING RISKS ANALYSIS

A biostatistical method developed for multivariate analysis of factors influencing the type of and time to first failure, to avoid the first risk to occur preventing observation of later risks

Rights and permissions

Reprints and permissions

About this article

Cite this article

Haffty, B. Can molecular markers predict local, regional and distant metastasis in head and neck cancer?. Nat Rev Clin Oncol 2, 132–133 (2005). https://doi.org/10.1038/ncponc0102

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc0102

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing